-- Earnings Flash (NTUS) NATUS MEDICAL INCORPORATED Reports Q1 EPS $0.22, vs. Street Est of $0.26
4:22PM ET 5/05/2022 MT Newswires...
Quotes Snapshot > NTUS
Natus Medical Inc NTUS:NASDAQ
Last Price$32.86Cboe Real-Time Last Sale as of 9:48AM ET 6/30/22
Cboe Real-Time Quotes
Realtime quote and/or trade prices are not sourced from all markets
Cboe Real-Time Quotes
Realtime quote and/or trade prices are not sourced from all markets
Today's Change+0.16(0.49%)
Bid (Size)$32.79 (100)
Ask (Size)$32.90 (100)
Day Low / High$32.80 - 33.14
Volume14.9 K
Read more news Recent News
Natus Medical Q1 Non-GAAP EPS, Revenue Rise
4:19PM ET 5/05/2022 MT NewswiresNatus Medical (NTUS) on Thursday reported Q1 non-GAAP earnings of $0.22 per diluted share, up from $0.16 a year ago. A single analyst polled by Capital IQ...
Correction: Sector Update: Health Care Stocks Stumble Monday Afternoon
11:27AM ET 4/19/2022 MT Newswires(Corrects third paragraph to show Canadian valve manufacturer Velan Inc. shares were higher instead of lower in afternoon trading on Monday.) Health care...
Sector Update: Health Care Stocks Stumble Monday Afternoon
4:00PM ET 4/18/2022 MT NewswiresHealth care stocks continued to lose ground this afternoon, with the NYSE Health Care Index declining 1.3% while the SPDR Health Care Select Sector ETF...
View all Commentary and Analysis
Natus Medical (NTUS) Investor presentations - Slideshow
11:57AM ET 5/25/2022 Seeking AlphaMerger Arbitrage Mondays - Blackstone Acquires American Campus Communities
8:23AM ET 4/25/2022 Seeking AlphaNatus Medical Incorporated (NTUS) CEO Thomas Sullivan on Q4 2021 Results - Earnings Call Transcript
12:44PM ET 2/25/2022 Seeking AlphaNatus Medical Incorporated 2021 Q4 - Results - Earnings Call Presentation
9:47AM ET 2/25/2022 Seeking AlphaCompany Profile
Business DescriptionNatus Medical, Inc. provides medical device solutions focuses on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages. Its products are used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, sleep disorders, neuromuscular diseases and balance and mobility disorders. The company was founded by Maurizio Liverani, John Robert Camber Porter, William New, Jr., Brian Prinn and William W. Moore on May 26, 1987 and is headquartered in Middleton, WI. View company web site for more details
| Address | 3150 Pleasant View Road Middleton, Wisconsin 53562 |
| Phone | +1.608.829.8500 |
| Number of Employees | 1,729 |
| Recent SEC Filing | 06/17/2022 4 |
| President, Chief Executive Officer & Director | Thomas J. Sullivan |
| Vice President-Global Operations | Seán Langan |
| Chief Financial Officer & Executive Vice President | Benjamin Drew Davies |
| Vice President-Global Research & Development | Ivan Pandiyan |
Company Highlights
| Price Open | $32.90 |
| Previous Close | $32.70 |
| 52 Week Range | $20.90 - 33.93 |
| Market Capitalization | $1.1 B |
| Shares Outstanding | 34.6 M |
| Sector | Health Technology |
| Industry | Medical Specialties | Next Earnings Announcement | 08/04/2022 |
Options Summary
| Call Open Interest (1d)* |  |
| Put Open Interest (1d)* | |
| Call Volume (1d)* | |
| Put Volume (1d)* | |
| Put Call Open Interest Ratio (1d)* | |
| Put Call Volume Ratio (1d)* | |
| * Data delayed by up to 15 minutes |
View all fundamentalsFundamentals
| Price / Earnings | 88.24 |
| Earnings per Share | $0.62 |
| Beta vs. S&P 500 | N/A |
| Revenue | $530.9 M |
| Net Profit Margin | 2.65% |
| Return on Equity | 2.99% |
Analyst Ratings as of 01/16/2020
| Buy | |
| Overweight | |
| Hold | |
| Underweight | |
| Sell | |
Consensus Recommendation | |